The trademark AURORA was filed by Immunocore Limited, a corporation established under the laws of the United Kingdom of Great Britain and Northern Ireland (the "Applicant"). The application was published for oppositions on April 5, 2021, and received one opposition filed on July 5, 2021 by BELLA AURORA LABS, S.A. on (a) Identity of marks and Goods and Services, (b) Likelihood of confusion. the opponent was represented by PONS IP, S.A. and proceedings were handled in English, and the oppositon was dismissed by the Euorpean Union Intellectual Property Office with decision issued July 5, 2021
The application was filed in English, and English was also language of all opposition proceedings (French was selected as the second language).
Goods And Services
The mark was filed in class 5 with following description of goods:
Biological preparations for the treatment of cancer
Biological preparations for the treatment of viral infections
Biological preparations for the treatment of autoimmune diseases
Biological preparations for medical use
Immunotherapeutic drugs
Reagents for medical use
Diagnostic preparations
Diagnostic reagents for medical use
Preparations and reagents used in connection with drug discovery, namely the identification of pharmaceutical targets and/or the development of molecules to be used for medicinal or therapeutic purposes
Preparations and reagents used in connection with protein engineering and biological drug development.
The mark was filed in class 42 with following description of goods:
Scientific and technological services and research and design relating thereto
Pharmaceutical research and development services
Pharmaceutical testing and clinical trials
Research and development in the biotechnology field
Drug discovery, namely the identification of pharmaceutical targets and/or the development of molecules to be used for medicinal or therapeutic purposes
Protein engineering and biological drug development
Provision of information and consultancy in relation to the aforesaid services.